CHAMEDITECH participated in the IMCAS World Congress 2022 held from June 3 to 5 and presented the effectiveness and safety of its product, HyaFilia SMV.
This presentation's speaker was a specialist in plastic surgery, Dr. Aydin SARAY (Turkey), the topic was "Patient tailored design: How she makes V?".
He spoke in a case in various treatment areas (lipped, palmar wrinkles, jaw, nose, temples, etc.) based on the characteristics of HyaFilia SMV and its product's safety through the results of our test during 6 months with the patient, then he received keen attention from the medical staff who participated in the field.
Hyafilia SMV emphasized safety by increasing physical crosslinking based on the technology of CHA-HEART(Cross-linked Hyaluronic Acid of Hight concentration Emulsion Arrangement & Refinement Technology) and minimizing chemical crosslinking substance BDDE (Butan Diol Diglycidyl Ether).
In addition, by increasing the cohesiveness compared to existing products, you can expect natural treatment results in better harmony with surrounding tissues during the procedure.
The IMCAS World Congress 2022 attended by 326 companies and about 12,000 medical staff and officials from 110 countries around the world, and CHAMEDITECH promoted HA Filler "HYAFILIA S, M, V", skin booster "CELLTERMI PROFESSIONAL" and lifting threads "HILIFT".
CHAMEDITECH attended Dubai Derma 2022 in February and 2022 AMWC (International Society of Beauty and Antiaging) in March to continue promoting its brand to overseas medical staff and industry officials.
In addition, we do continuous research activities and work harder as a Global Bio Aesthetic Company through product development.
Thank you.